Edwards Lifesciences Corp (EW)

Net profit margin

		Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Net income	US$ in thousands	4,174,600	1,402,400	1,521,900	1,503,100	823,400
Revenue	US$ in thousands	5,439,500	6,004,800	5,382,400	5,232,500	4,386,300
Net profit margin		76.75%	23.35%	28.28%	28.73%	18.77%

December 31, 2024 calculation

Net profit margin = Net income ÷ Revenue
= $4,174,600K ÷ $5,439,500K
= 76.75%

The net profit margin of Edwards Lifesciences Corp has shown fluctuating trends over the past five years. The margin was 18.77% as of December 31, 2020, which increased to 28.73% by December 31, 2021. In the subsequent year, it slightly decreased to 28.28% by December 31, 2022. By December 31, 2023, the net profit margin dropped to 23.35%. The most significant leap was observed by the end of December 31, 2024, where the margin surged to an impressive 76.75%. These changes suggest fluctuations in the company's profitability over the years, indicating varying levels of efficiency in cost management and revenue generation. It is essential for stakeholders to closely monitor these fluctuations to assess the company's financial performance and sustainability.